{
  "disease_name": "Endometrial cancer",
  "synonyms": [
    "Uterine cancer",
    "Cancer of the endometrium"
  ],
  "summary": "Endometrial cancer is a cancer that arises from the endometrium, the lining of the uterus. It is characterized by abnormal cell growth that can invade or spread to other parts of the body. It is the most common type of uterine cancer and primarily affects women after menopause.",
  "causes": [
    "Abnormal growth of cells",
    "Excessive estrogen exposure",
    "Genetic mutations (e.g., in PTEN, TP53, MLH1, MLH2, MSH2, MSH6, PMS2, ARID1A, PIK3CA, KRAS, CTNNB1, FGFR2, SPOP)",
    "Endometrial hyperplasia",
    "Endometrial intraepithelial neoplasia"
  ],
  "risk_factors": [
    "Obesity",
    "Insulin resistance",
    "Diabetes mellitus (Type II)",
    "Estrogen-only hormone replacement therapy (HRT)",
    "Early menarche",
    "Late menopause",
    "Never having had a child",
    "Polycystic ovary syndrome (PCOS)",
    "Tamoxifen use",
    "Family history of endometrial cancer",
    "Lynch syndrome",
    "Cowden syndrome",
    "Previous ovarian cancer",
    "Previous radiotherapy to the pelvis",
    "Ovarian granulosa cell tumors",
    "Thecomas",
    "Low immune function",
    "High blood pressure",
    "Prolonged sitting",
    "Increasing age",
    "Black women (in the US, for Type II)",
    "Trans men on testosterone without hysterectomy",
    "Higher circulating testosterone levels in women"
  ],
  "symptoms": [
    "Vaginal bleeding not associated with a menstrual period",
    "Vaginal bleeding or spotting after menopause",
    "Abnormal menstrual cycles (pre-menopause)",
    "Extremely long, heavy, or frequent episodes of bleeding (pre-menopause)",
    "Thin white or clear vaginal discharge (postmenopausal women)",
    "Lower abdominal pain",
    "Pelvic pain",
    "Pelvic cramping",
    "Painful sexual intercourse",
    "Painful urination",
    "Pain with urination",
    "Pus in the uterus (pyometra)",
    "Blood collected in the uterus (hematometra)",
    "Enlarged uterus",
    "Pelvic mass"
  ],
  "diagnosis": [
    "Physical examination",
    "Endometrial biopsy",
    "Dilation and curettage (D&C)",
    "Transvaginal ultrasound",
    "Magnetic resonance imaging (MRI)",
    "CT scans",
    "Pelvic examination",
    "Cervical screening test (Pap smear - not typically sufficient)",
    "Hysteroscopy (in conjunction with biopsy)",
    "Chest x-ray",
    "Liver function tests",
    "Kidney function tests",
    "CA-125 tumor marker test"
  ],
  "treatments": [
    "Abdominal hysterectomy (total removal of the uterus)",
    "Bilateral salpingo-oophorectomy (removal of Fallopian tubes and ovaries)",
    "Radiation therapy",
    "Chemotherapy",
    "Hormone therapy (progestins, tamoxifen, megestrol acetate, medroxyprogesterone, letrozole, anastrozole)",
    "Targeted therapy (e.g., Dostarlimab, PARP inhibitors like olaparib, mTOR inhibitors like temsirolimus, ridaforolimus, bevacizumab, tyrosine kinase inhibitors, ixabepilone)",
    "Bone marrow or stem cell transplant (not explicitly mentioned for endometrial cancer, but a general cancer treatment)",
    "Supportive and palliative care",
    "Progestins (for fertility preservation)",
    "Tamoxifen therapy (for fertility preservation)",
    "Cytoreductive surgery",
    "Pelvic exenteration",
    "Intensity modulated radiation therapy",
    "Hyperbaric oxygen therapy"
  ],
  "related_genes": [
    "PTEN",
    "TP53",
    "MLH1",
    "MLH2",
    "MSH2",
    "MSH6",
    "PMS2",
    "ARID1A",
    "PIK3CA",
    "KRAS",
    "CTNNB1",
    "FGFR2",
    "SPOP",
    "BRCA1 (indirectly via tamoxifen)",
    "BRCA2 (indirectly via tamoxifen)",
    "Her2/neu"
  ],
  "subtypes": [
    "Endometrioid carcinoma",
    "Serous carcinoma",
    "Clear cell carcinoma",
    "Mucinous carcinoma",
    "Mixed or undifferentiated carcinoma",
    "Malignant mixed MÃ¼llerian tumor",
    "Endometrial stromal sarcoma",
    "Type I endometrial cancer",
    "Type II endometrial cancer",
    "Uterine sarcoma"
  ]
}